David Alex is an experienced professional with over 25 years in the pharmaceutical and biotechnology industries, currently serving as the Executive Director of National Accounts & Market Access at Gilead Sciences since 2021. Previously, David held several roles at Gilead, including Executive Director of Immunology Sales & Operations and HIV Sales & Operations, and worked at Merck as a Professional Representative in Immunology/Pulmonology Sales. David is responsible for managing approximately $1.6 billion in annual sales and leads a team of 24 employees while collaborating with various departments to ensure organizational objectives are met. David is pursuing a BS in Finance & General Business at Miami University.
This person is not in any teams
This person is not in any offices